Semaglutide

Semaglutide is a GLP-1 receptor agonist analogue designed for metabolic pathway research. Its peptide-based structure offers prolonged receptor interaction, making it useful for studies involving glucose signaling, satiety regulation, and incretin-related mechanisms. Its enhanced molecular stability supports extended observation windows in controlled research conditions.

Product Info

Molecular formula: C187H291N45O59
Molecular weight: 4113.6
Purity: 99%+
Sequence: H-Aib-Glu-Glu-Glu-Glu-Glu-Aib-Ser-Gln-Tyr-Leu-Leu-Lys-Asp-Phe-Arg-Leu-Gln-Aib-Leu-Ser